Andy Batts
Long only, value, growth, momentum

NxStage Gaining Ground On Growing Adoption Of Home Hemodialysis

NxStage Medical (NASDAQ:NXTM) is a medical device company in the dialysis therapy market that develops, manufactures and markets innovative products for the treatment of kidney failure, fluid overload and related blood treatments and procedures. It is a smaller company in the market compared to established players, such as Fresenius (NYSE:FMS) and DaVita (NYSE:DVA). These two companies account for more than half of the conventional dialysis market segment in the United States. However, NxStage Medical's System One is currently the only portable system specifically indicated for use in the home hemodialysis market segment in the United States.

NXTM debuted in the stock market in late 2005. In 2011 NXTM crossed $25 before witnessing a secular...

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details